Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

UK budget aims to attract & keep pharma manufacturers

24-Mar-2011 - The UK has drafted a budget to attract and keep business but there are still significant barriers to investment, warns the CIA.

Lonza wins manufacturing deals with Enobia and Athera

23-Mar-2011 - Switzerland-based Lonza has signed two new manufacturing deals with pharmaceutical firms that look set to improve capacity utilisation.

GSK joins UK Gov innovative manufacturing initiative

23-Mar-2011 - GSK is participating in a UK Government-backed innovative manufacturing initiative aimed at revitalising the sector.

Gerresheimer buys Bazilian plastic pack firm Vedat

23-Mar-2011 - Gerresheimer has bought Brazilian pharmaceutical plastic packaging maker Vedat, citing rapid growth of the country’s drug market, particularly the generics segment, as the main driver for the acquisition.

News in brief

IPCA gets MHRA OK for India API plant

10-Mar-2011 - API maker IPCA laboratories has received UK MHRA approval for its formulations and production unit in Indore, India.

Helsinn says cytotoxics plant will be up and running in 2012

08-Mar-2011 - Swiss pharmaceutical ingredient maker Helsinn says its new cytotoxic API production plant will be operational for laboratory-scale projects early next year.

Thermo rolls out predictive liver toxicity assay

08-Mar-2011 - Thermo Fisher Scientific has launched a predictive assay that, it claims, can assess a drug candidate’s potential to cause liver damage earlier than traditional methods.

CRL adds Pfizer-developed R&D lab models to portfolio

07-Mar-2011 - Charles River Laboratories (CRL) said it will distribute several Pfizer-developed R&D models, in a deal that continues the US CRO’s efforts to expand its lab animals business.

Lonza using energy broker to cut costs at production sites

02-Mar-2011 - Lonza is working with energy broker Usource to reduce costs at a number of its US production and R&D facilities.

Clondalkin to buy Catalent printed components unit

02-Mar-2011 - Clondalkin is to buy the printed components unit from Catalent as part of an ongoing acquisition strategy in the strong sector growth.

Carbogen Amcis to restructure ops and cut staff

24-Feb-2011 - CMO Carbogen Amcis will restructure its Swiss manufacturing operations and cut jobs to combat “inadequate profitability” in a new plan announced late yesterday.

Mass-market pharma may build profit making supply chains

24-Feb-2011 - Mass-market drug manufacturers can turn a fixed cost into a service-providing revenue generator by investing in an agile supply chain, says PwC.

Radical overhaul of ill-equipped pharma supply chains needed

22-Feb-2011 - A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, says PwC.

Endeavour rolls out thioamides targeting cancer R&D

21-Feb-2011 - UK-based Endeavour Specialty Chemicals has launched a range of thioamide intermediates, citing growing evidence of their potential role in development of new cancer treatments.

West’s operating profit tumbles as restructuring charges hit

21-Feb-2011 - Operating profit at West tumbled in the fourth quarter as restructuring charges and the lack of H1N1 affected results.

updated

CEO: Sanofi may provide Genzyme with fill/finish long term

17-Feb-2011 - Sanofi Aventis’ CEO, Chris Veibacher, said the French drugmaker may look at providing some fill/finish capacity for Genzyme in the long term.

Capsugel buys FlexTab to expand into high value markets

17-Feb-2011 - Pfizer’s Capsugel unit has bought an injection molding technology that, it believes, will expand its capsule filling business into new “high value segments.”

European Parliament votes yes on falsified medicines directive

17-Feb-2011 - The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.

Canada lost more than 3,600 pharma jobs in H2 2010

16-Feb-2011 - Canada lost more than 3,600 pharmaceutical jobs in the second half of 2010 as domestic and export sales slowed.

Live blog of news & views from Informex 2011 – replay

10-Feb-2011 - in-PharmaTechnologist presents a replay of our live blog covering all the news, views and multimedia from Informex 2011.

News in brief

ScinoPharm begins Viibryd production; announces facility expansion

09-Feb-2011 - Global API service provider, ScinoPharm, is to begin the commercial manufacture of vilazodone hydrochloride, the active pharmaceutical ingredient (API) in Clinical Data Inc.'s new antidepressant, Viibryd.

Novasep and instrAction team on taxane process development

09-Feb-2011 - Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.

Bill to tackle prescription drug shortages enters US Senate

09-Feb-2011 - A bill requiring biopharm manufacturers to give the FDA early notification of potential drug shortages has been introduced to the US Senate.

Lilly staff bonuses tied to R&D progression

08-Feb-2011 - Eli Lilly will factor the performance of candidate drugs into employee bonuses in future under a scheme designed to stress the importance of R&D.

UK issues supply chain guide to prevent drug shortages

07-Feb-2011 - Biopharm manufacturers should hold a volume of buffer stock to ensure it can maintain supply during fluctuations in demand, says UK guidance.

Sign up for your free newsletter